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a  b  s  t  r  a  c  t
The  glucoregulatory  hormones  insulin  and  glucagon  are  released  from  the  - and  -cells  of the  pancreatic
islets.  In  both  cell  types,  secretion  is  secondary  to  ﬁring  of action  potentials,  Ca2+-inﬂux  via  voltage-
gated  Ca2+-channels,  elevation  of  [Ca2+]i and  initiation  of  Ca2+-dependent  exocytosis.  Here  we  discuss
the  mechanisms  that  underlie  the  reciprocal  regulation  of  insulin  and  glucagon  secretion  by  changes
in plasma  glucose,  the  roles  played  by  different  types  of  voltage-gated  Ca2+-channel  present  in  - and
-cells  and the  modulation  of hormone  secretion  by  Ca2+-dependent  and  -independent  processes.  We
2+
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also  consider  how  subtle  changes  in  Ca -signalling  may  have  profound  impact  on  -cell  performance
and  increase  risk  of  developing  type-2  diabetes.
© 2011 Elsevier Ltd. Open access under CC BY license.iabetes
. Introduction
Pancreatic islets play a central role in the systemic regu-
ation of metabolism. They do so by secreting two hormones
ith opposing effects on plasma glucose concentration: insulin
nd glucagon, which lowers and increases plasma glucose lev-
ls, respectively. The pancreatic islets are small aggregates of
ndocrine cells with a diameter of 100–200 m and consist of
1000 endocrine cells. The three major endocrine cells within the
slets are the insulin-producing -cells, glucagon-secreting -cells
nd somatostatin-releasing -cells which in man  comprise ∼50%,
5% and 15% of the islet cell number, respectively [1].
Diabetes mellitus is a major metabolic disorder currently affect-
ng 5–10% of the population in the western societies [2].  There are
wo forms of diabetes mellitus. In type-1 diabetes, the pancreatic
-cells are destroyed and patients with this form of the disease
equire exogenous insulin to normalise plasma glucose levels. In
ype-2 diabetes (T2D), which accounts for 90% of all diabetes, the
-cells largely remain intact but insulin is not released in sufﬁcient
mounts. In both forms of diabetes, the metabolic consequences
f the lack of insulin are exacerbated by oversecretion of glucagon
3,4].
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Open access under CC BY license.Electrophysiological studies on isolated - and -cells from both
rodent (mouse, rat and guinea pig) and human islets have revealed
that they are electrically excitable and that they contain a number
of voltage-dependent and -independent ion channels [5,6]. Here we
will summarize - and -cell electrical activity, the role of the dif-
ferent ion channels and how action potential ﬁring translates into
increases in the cytoplasmic calcium level ([Ca2+]i) that culminates
in exocytotic fusion of the hormone-containing secretory vesicles.
2. The consensus model for glucose-induced insulin
secretion
Electrical activity from mouse pancreatic -cells was ﬁrst
reported by Dean and Matthews in 1968 who  impaled intact mouse
islets with sharp intracellular electrodes [7].  The next 15 years or
research focused on the characterization of this electrical activ-
ity and its regulation by glucose [8].  When exposed to glucose
concentrations too low to evoke insulin secretion (<5 mM), the -
cell is electrically inactive and the membrane potential stable and
negative (typically −70 mV  or below). Elevation of glucose to con-
centrations above 6 mM (the threshold for insulin secretion in mice)
leads to membrane depolarization and, when a certain threshold
potential is exceeded (−55 mV  to −50 mV), the -cells starts ﬁr-
ing action potentials. These normally peak at voltages below 0 mV,
although overshooting action potentials are occasionally observed.
At glucose concentrations between 6 and 17 mM,  electrical activity
is oscillatory and consists of groups of action potentials superim-
posed on depolarized plateaux that are separated by the repolarized
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It should be emphasized that ‘intrinsic’ and ‘paracrine’ modes of
-cell regulation are not mutually exclusive. Indeed, there is goodP. Rorsman et al. / Cell 
electrically silent) intervals. Glucose produces a concentration-
ependent increase in the fraction active phase at the expense of
he silent phase. When the glucose concentration exceeds 20 mM,
lectrical activity is more or less continuous.
Membrane potential recordings with sharp intracellular elec-
rodes also allowed the effects of pharmacological agents like
olbutamide and diazoxide [9],  effects of channel blockers like
etraethylammonium [10], hormones and neurotransmitters such
s galanin, adrenaline and acetylcholine [11] to be documented.
hese studies also enabled the demonstration of electrical coupling
etween -cells within the same islet [12].
However, it was not until the patch-clamp technique was
pplied to pancreatic islet cells in the 1980s that the ion
hannels underlying -cell electrical activity could be studied
nder voltage-clamp control. A breakthrough was  the identiﬁ-
ation glucose-sensitive K+-channel, postulated on the basis of
adioisotopic measurements in the 1970s [13], that underlie the
lucose-induced membrane depolarization [14] and the subse-
uent ﬁnding that it is regulated by changes in the intracellular ATP
nd ADP concentrations [15]. Because of its high sensitivity to intra-
ellular ATP, this channel is now referred to as the ATP-sensitive
+-channel (KATP-channel).
Patch-clamp measurements also allowed the characterization
f the voltage-dependent Ca2+ and K+-channels involved in -cell
ction potential ﬁring [16].
Based on these ﬁndings, a consensus model for glucose-
timulated insulin secretion from mouse or rat islets was proposed
6]. In this model, glucose (via its metabolism and elevation of the
ytoplasmic ATP/ADP-ratio) leads to a concentration-dependent
eduction in KATP-channel activity. KATP-channel activity main-
ains a negative membrane potential in mouse -cells and closure
f these channels unmasks the depolarizing inﬂuence of an (as
et) poorly characterized conductance, which accounts for the
nitial depolarization up to the threshold for action potential
ring. The action potentials involve activation of voltage-gated
-type Ca2+-channels and the associated Ca2+-entry leads, via
levation of the submembrane [Ca2+]i, to stimulation of Ca2+-
ependent exocytosis of the insulin-containing secretory granules
17].
Sulphonylurea drugs (like tolbutamide and glibenclamide) by-
ass glucose metabolism and closes the KATP-channels by direct
nteraction with the channel [18] but the downstream effects are
argely the same.
In addition to the stimulatory effect mediated by closure of KATP-
hannels, glucose also augments insulin release by an effect exerted
istal to the elevation of [Ca2+]i. These two effects are referred to
s the triggering and amplifying effects of glucose [19]. It should be
mphasized that the amplifying effect requires elevation of [Ca2+]i
ut that glucose somehow increases the release competence of the
ecretory granules and their likelihood of undergoing exocytosis in
esponse to a given increase in [Ca2+]i. The identity of the intracel-
ular second messenger mediating the amplifying effect remains
bscure but it is of interest that increases and decreases in ATP
nd ADP concentration, respectively, mimic  the effect of an eleva-
ion of glucose on exocytosis [20]. Accordingly, the triggering and
mplifying effects of glucose may  be mediated by the same second
essenger(s).
Because of the electrical coupling in mouse islets, [Ca2+]i oscilla-
ions resulting from action potential ﬁring in the individual -cells
re synchronized across the entire islet [21,22].
Although studies on human -cells are not as elaborate as for
ouse -cells, it seems clear that the ‘consensus model’ also applies
o these cells (Fig. 1): elevation of glucose triggers electrical activ-
ty [23] and elevation of [Ca2+]i [24]. Bursting electrical activity
nd [Ca2+]i oscillations, similar (but not identical) to those seen in
ouse islets, can be observed in recordings from -cells withinm 51 (2012) 300– 308 301
intact human islets (Fig. 1B–C). However, the [Ca2+]i responses
in the individual cells within human islets appear less well syn-
chronized than in mouse islets [1,24].  This suggests that electrical
coupling between individual -cells may  not be as strong in human
as in mouse islets, perhaps as a result of the less organized archi-
tecture of the human islets with the -cell ‘syncytium’ being
interrupted by strands of non--cells [1].
3. The ‘lack of consensus model’ for glucose-regulated
glucagon secretion
Compared to the detailed understanding of glucose-sensing in
-cells, the knowledge about this process in glucagon-secreting
-cells may  seem rudimentary. Unlike -cells, -cells are electri-
cally active in the absence of glucose and generate overshooting
action potentials [25,26].  Surprisingly, -cells are equipped with
KATP-channels with the same subunit composition as in the -
cells [27]. The role of these channels in -cells, the presence of
which was  ﬁrst reported in 1993 [28], has remained an enigma.
How can the same channel mediate stimulation in one cell (the -
cell) and inhibition in another cell (the -cell)? This conundrum
led to the belief that these channels were perhaps not so impor-
tant for the physiological regulation of glucagon secretion. This
notion was  supported by the ﬁnding that KATP-channel activity was
almost immeasurably low even in -cells exposed to very low glu-
cose concentrations [29,30]. Rather, the metabolic regulation of
glucagon secretion was postulated to be mediated by paracrine
factors released from neighbouring - and -cells [5].  Potential
paracrine regulators include GABA, Zn2+, somatostatin and insulin.
However, a problem with this hypothesis is that glucagon secre-
tion, at least in mouse islets, is regulated over a range of glucose
concentrations (below 4–5 mM)  not associated with any detectable
stimulation of insulin and somatostatin secretion. This argues that
the -cells possess some sort of intrinsic glucose-sensing which
operates independently of paracrine signalling [31,32]. The nature
of the intrinsic regulation remains debated. We have proposed that
KATP-channels play a similar role in -cells as in -cells and that
glucose-dependent closure of these channels results in membrane
depolarization. Because - and -cells express different comple-
ments of voltage-gated ion channels, membrane depolarization
results in reduced rather than increased electrical excitability (as
in -cells) [31].
The -cell action potentials involve activation of TTX-sensitive
voltage-gated Na+-channels. The signiﬁcance of these channels for
glucagon secretion is illustrated by the strong inhibitory effect
of this blocker on glucagon secretion [33]. Voltage-gated Na+-
channels exhibit a dual dependence on membrane potential.
Whereas short depolarizations increase the open probability, sus-
tained depolarizations (even those that are not large enough to
activate the channels) make the channel enter a non-conducting
inactivated state. If the depolarization is long enough, it will exert
a TTX-like effect on -cell electrical activity and glucagon secre-
tion. We  have found that depolarizations of only a few millivolts
are sufﬁcient to reduce action potential height by 10–20 mV.  Such
an effect can be expected to have a dramatic effect on glucagon
secretion because exocytosis declines exponentially by >10% for
every millivolt reduction of action potential height once their peak
voltage goes below 0 mV  [34].evidence for paracrine regulation of glucagon secretion [35–38] but
its role is likely to be particularly signiﬁcant under conditions asso-
ciated with stimulation of insulin and/or somatostatin secretion (or
other factors co-released with these hormones).
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Fig. 1. Stimulus-secretion coupling of human -cells. (A) Glucose uptake via Glut1 leads to accelerated glucose metabolism, increased ATP production and closure of the
ATP-regulated K+-channels (KATP-channels), consisting of the pore-forming subunit Kir6.2 and the sulphonylurea-binding protein SUR1. The increased membrane resistance
(Rm↑) resulting from closure of the KATP-channels allows occasional spontaneous opening of T-type Ca2+-channels to depolarise the -cell ( ↓) and this leads to regenerative
opening of additional T-type Ca2+-channels and further membrane depolarization that culminates in rapid activation of L-type Ca2+-channels and voltage-gated Na+-channels
during  the upstroke of the action potential. The action potential culminates in the opening of P/Q-type Ca2+-channels and the associated Ca2+-inﬂux triggers exocytosis of
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rom  a -cell in an intact islet in response to an elevation of glucose from 1 to 6 m
uman islets when in response to an elevation of glucose from 1 to 6 mM.
. Ca2+-channels in -cells and their role in insulin
ecretion
Mouse -cells are equipped with dihydropyridine-sensitive
a2+-channels (50% of the whole-cell Ca2+-current), SNX482-
ensitive R-type Ca2+-channels (25%) and P/Q-type Ca2+-channels
10–15%) [39]. Pharmacological blockade of L-type Ca2+-channels
eads to transient inhibition of glucose-induced electrical activ-
ty but it subsequently resumes in the continued presence of
he blocker [40]. Pancreatic islets have variably been reported
o express L-type Ca2+-channels containing 1C (Cav1.2) and 1D
Cav1.3) pore-forming subunits [41,42]. However, we  observed
o differences in the Ca2+-current density between wildtype and
av1.3/1D-deﬁcient -cells [43]. By contrast, the Ca2+-current
ensity was reduced by ∼50% in -cells from Cav1.2−/− mice and
he residual current was resistant to dihydropyridines antagonists
like isradipine) and agonists (like BAYK8644) [39,44]. We  there-
ore concluded that Cav1.2 is the principal L-type Ca2+-channels
ubtype in mouse -cells.
Glucose-induced action potential ﬁring and [Ca2+]i oscillations
ere maintained in -cells/islets from mice lacking Cav1.2 (1C)
-type Ca2+-channels. Nevertheless, glucose-induced insulin secre-
ion is strongly reduced in Cav1.2−/− islets. Glucose-induced insulin
ecretion follows a biphasic time course consisting of a rapid but
ransient 1st phase followed by a slower and sustained 2nd phase
17]. Both phases were reduced in Cav1.2-deﬁcient islets [39].
hus, Ca2+-inﬂux via 1C-containing L-type Ca2+-channels is tightly
inked to insulin exocytosis.
Experiments on islets from mice lacking R-type Ca2+-channels
Cav2.3/1E knock-out mice) and the impact of the R-type Ca2+-
hannel blocker SNX482 indicate these Ca2+-channels may play a
ole in the supply of new secretory granules to the release sites.
his is suggested by the observation that whereas 1st phase insulin
ecretion was unaffected by pharmacological/genetic inhibition of
-type Ca2+-channels, 2nd phase secretion was strongly reduced
45].
There are some important differences between human and
ouse -cells in terms of Ca2+-channel expression [46]. First,
nsulin exocytosis in human -cells shows a strong dependence on
/Q-type Ca2+-channels. Second, human -cells are equipped with
-type Ca2+-channels that start activating at membrane potentialss action potential repolarization. (B) Glucose-induced electrical activity recorded
te oscillatory electrical activity. (C) Elevation of [Ca2+]i in a -cell within an intact
as negative as −60 mV.  Third, R-type Ca2+-channels are not at all
expressed in human islets.
In mouse -cells, the Ca2+-currents can be modulated by protein
phosphorylation: activation of PKA and PKC leads to slight (20%)
increase in Ca2+-entry [47,48].  However, the effects of physiological
agonists (like GLP-1 and acetylcholine) acting via these pathways
are in general much weaker [49,50]. There is evidence suggesting
that the Ca2+-channels are subject to stronger modulation by ago-
nists in rat -cells [51] and in human -cells (own unpublished).
Nevertheless, it seems justiﬁed to conclude that most of the hor-
monal modulation of insulin secretion (inhibition or stimulation)
is exerted at the level of exocytosis itself.
5. Ca2+-channels in -cells
The ﬁrst characterization of -cell Ca2+-currents was per-
formed using guinea pig -cells and indicated that they contain
low-threshold T-type Ca2+-channels and two types of high voltage-
activated (HVA) Ca2+-channels [52]. More recent work suggests
that mouse -cells express a similar complement of Ca2+-channels
[26,53,54]. We  proposed, based on the use of nifedipine and -
conotoxin that mouse and rat -cells contain L- (80%) and N-type
HVA Ca2+-channels (20%) [55]. However, the effect of -conotoxin
was  reversible, unlike what has been demonstrated for its inter-
action with N-type Ca2+-channels, suggesting that the effect of
-conotoxin in -cells may  be unspeciﬁc [56]. Indeed, mouse -
cells express only low levels of Cav2.2 (N-type) but high levels of
Cav2.1 (P/Q-type) (own unpublished). It is possible therefore that
mouse -cells express P/Q- rather than N-type Ca2+-channels in
addition to L-type Ca2+-channels. We  have subsequently conﬁrmed
that -cells contain an HVA Ca2+-current component that can be
blocked by the P/Q-type Ca2+-channel blocker -agatoxin and that
-conotoxin exerts no additive inhibitory effect in -cells already
exposed to -agatoxin (own unpublished).
Human -cells are also equipped with P/Q- and L-type Ca2+-
channels [34]. However, their relative contribution of L- and
P/Q-type Ca2+-channels to Ca2+-entry is opposite to that in mouse
-cells (P/Q-type contributing 70% and L-type only 20%). Like their
rodent counterparts, human -cells contain low-threshold T-type
Ca2+-channels that may  be involved in the pace-making of the
-cell (i.e. the interspike depolarization between two successive
P. Rorsman et al. / Cell Calcium 51 (2012) 300– 308 303
Fig. 2. Ca2+-signalling in human -cells. (A) Schematic action potential in human -cell. Contribution to action potential of T- (Ca[T]), L- (Ca[L]) and P/Q-type Ca2+-channels
(Ca[P/Q]), TTX-sensitive Na+-channels (NaV), transient A-type K+-current (KV[A]) and delayed rectifying K+-current (KV[DR]). P/Q-type Ca2+-channels, linked to glucagon
exocytosis, open only at the peak of the action potential (highlighted in red) and if the peak voltage of the action potential is reduced (right), fewer P/Q-type Ca2+-channels
will  open with resultant suppression of glucagon secretion. Glucose may reduce spike height via membrane depolarization and this in turn leads to voltage-dependent
inactivation of NaV, KV(A) and Ca(T) and under these conditions, action potential ﬁring may depend only on Ca(L) and KV(DR) channel activity. (B) Effects of increasing glucose
from  1 to 6 mM on spontaneous [Ca2+]i oscillations in an individual cell (assumed to be an -cell) within an intact human pancreatic islet. Note that glucose has no major
inhibitory effect during >10 min. (C) Effects of -agatoxin (200 nM) and isradipine (10 M)  on [Ca2+]i measured in a cell spontaneously active at low glucose. Note small
effect  of -agatoxin and that subsequent addition of isradipine exerts a stronger inhibitory effect. Effect of -agatoxin irreversible so both P/Q and L-type Ca2+-channels
are  blocked following the addition of isradipine. Experiments in B–C were conducted by Dr CE Ward. Trace in C is taken from [34]. (D) Differential roles (hypothetical) of
L-  and P/Q-type Ca2+-entry on release of glucagon-containing secretory granules and acetycholine-containing synaptic like microvesicles (SV). Note that L- and P/Q-type
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ction potentials). Fig. 2A depicts schematically how the voltage-
ated ion channels documented in human -cells contribute to
ifferent phases of the action potential.
. Economical use of Ca2+-channels in -cells
The Ca2+-channel density in -cells is very low (10 pA/pF mea-
ured during depolarizations to 0 mV  in the presence of 10 mM
a2+) [16]. With a single-channel current amplitude of 0.2 pA (at
 mV  with 10 mM Ca2+) [57] and a speciﬁc membrane capacitance
f 10 fF m−2 [58], the above current density corresponds to 0.5
a2+-channels per m2. A similar low Ca2+-channel density was
erived by stationary ﬂuctuation analysis [43]. This is only 5–10%
f the channel density in adrenal chromafﬁn cells but apparently
nough to allow the -cell to secrete adequate amounts of insulin.
learly, the -cell has developed a means to ensure efﬁcient usage
f the limited amounts of Ca2+ entering the cell. It is noteworthy
hat although [Ca2+]i remains elevated for a considerable period
fter a membrane depolarization, exocytosis only proceeds during
he depolarization, echoing the activity of the Ca2+-channels [59].
his behaviour indicates that exocytosis in the -cell is controlled
y [Ca2+]i just below the inner mouth of the Ca2+-channels. It is
mplicit from this concept that only secretory granules within these
active zones’ of elevated [Ca2+]i (<10 nm from the inner mouth of
he Ca2+-channels) will undergo exocytosis. The ﬁnding that rapid
xocytosis is resistant to intracellular application of 10 mM EGTA
s consistent with this scenario [60]. Upon membrane repolariza-
ion and Ca2+-channel closure, the active zones almost instantly
ollapse and this accounts for the rapid termination of exocytosis.On-cell single-channel measurements of Ca2+-channel activity
in mouse -cells have revealed that whereas most (>60%) mem-
brane patches contain no active Ca2+-channels at all, ∼20% of the
membrane patches contained 3 active channels [43] (Fig. 3A). This
is not expected from random distribution of the Ca2+-channels and
instead argues that the -cell Ca2+-channels associate into triplets.
This conceivably cancels out stochastic variation of channel activ-
ity and ensures that a release-competent secretory granule residing
close to the Ca2+-channels will be exposed to exocytotic levels of
[Ca2+]i long enough to trigger secretion. It is interesting that TIRF
imaging of the near-membrane [Ca2+]i transients evoked by brief
depolarizations concentrate to a few discrete areas (Fig. 3B). It is
tempting to speculate that these correspond to the triplets of Ca2+-
entry seen in the single-channel measurements.
In -cells in intact mouse pancreatic islets, the maximum rate
of exocytosis during depolarization to 0 mV is 30–40 fF/s [61]. This
corresponds to the secretion of 10–15 granules/s. When taking into
account that the -cell action potentials peak at −20 mV,  the steep
voltage dependence of exocytosis and that the measurements were
conducted in the presence of high intracellular cAMP, the rates of
exocytosis indicated by capacitance measurements are in reason-
able agreement with those observed in biochemical measurements
of insulin secretion (∼0.25 granule/s and cell) [17].
The relationship between the duration of the stimulus and the
exocytotic response is almost linear. This observation raises the
interesting possibility that biphasic glucose-induced insulin results
from the time-dependent changes in electrical activity and [Ca2+]i
following a step elevation of glucose [62] rather than the sequential
release of distinct functional pools of secretory granules that differ
304 P. Rorsman et al. / Cell Calcium 51 (2012) 300– 308
Fig. 3. Uneven Ca2+-channel distribution in -cells. (A) On-cell recording of Ca2+-channel activity in a single mouse -cell showing examples of patches containing no, 1,
2  or 3 channels. Values to the right indicate probability (in %) of the respective types of responses. Data from [43]. (B) TIRF image of an isolated ‘control’ -cell during a
50-ms  depolarization from −70 mV  to 0 mV.  Spatial resolution was  increased by the inclusion of 10 mM EGTA in intracellular medium (to restrict Ca2+-diffusion) and use
of  the low-afﬁnity Ca2+-indicator Oregon Green 6F (30 M).  Changes in [Ca2+]i are displayed in pseudocolours with black/blue and yellow/red corresponding to very low
and  high concentrations, respectively. Scale bars: 2 m.  The dotted line corresponds to the approximate footprint of the -cell. (C) As in B but obtained in a -cell treated
for  72 h with 0.5 mM palmitate. Experiments in panels B–C were conducted by Dr MB  Hoppa. Data from [60]. (D) Schematic representation of Ca2+-channels and secretory
granules in control cells. Secretory granules are tightly associated with voltage-gated Ca2+-channels. Stimulation with glucose leads to membrane depolarization, opening of
voltage-gated Ca2+-channels, localized increases in [Ca2+]i close to Ca2+-channels. This triggers exocytosis of the secretory granules. During long depolarizations (or when TEA
was  applied to broaden the action potentials), the active zones of elevated [Ca2+]i extend further away from the Ca2+-channels leading to moderate (50%) further stimulation
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uf  secretion. (E) As in D but in palmitate-treated -cells in which Ca2+-channels a
ncreases occur too far away from secretory granules to trigger their release. Howev
e.g.  by TEA). Under these conditions, the size of the active zones is increased so tha
ith regard to release competence and/or proximity to the release
ites [17]. This scenario may  also be in better agreement with
ecent TIRF imaging data suggesting that most granules released
n response to glucose are ‘restless newcomers’, not residing at
he plasma membrane but that arrive at the plasma membrane
uring glucose stimulation and then promptly undergo exocytosis
63]. It is tempting to speculate that the release sites correspond to
reas of the plasma membrane where L-type Ca2+-channels congre-
ate, the only place in the -cell where the submembrane [Ca2+]i is
ikely to rise to exocytotic levels. This scenario is supported by the
nding that 1st phase insulin secretion evoked by an increase in
lucose from 3 to 22 mM is maintained in mouse islets loaded with
he fast Ca2+-buffer BAPTA to an estimated intracellular concen-
ration of 1 mM [64]. By contrast, 2nd phase insulin secretion was
bolished, indicating that it depends on a more global elevation of
Ca2+]i.
Membrane depolarization alone without concomitant stimula-
ion of -cell metabolism (e.g. using high-K+ or tolbutamide in the
omplete absence of glucose) evokes only a transient stimulation of
nsulin secretion reminiscent of 1st phase glucose-induced insulin
ecretion [65]. Ultrastructural [66] as well as TIRF [60] and confocal
67] live-cell imaging experiments suggest that insulin secre-
ion evoked by this stimulation paradigm, unlike that evoked by
lucose [68], to a large extent involves granules already docked
elow the plasma membrane. Once this pool of docked gran-
les has been depleted, and in the absence of any supply ofcretory granules are not so tightly associated. Under these conditions, the [Ca2+]i
ulin secretion can be rescued when the duration of the depolarizations is increased
 granules not situated close to the Ca2+-channels undergo exocytosis.
new granules for release, exocytosis stops and this explains the
transient nature of insulin secretion under these experimental con-
ditions.
Collectively, the observations summarized above suggests that
insulin secretion evoked by membrane depolarization alone (e.g.
in response to elevated extracellular K+) and that elicited by glu-
cose result in the release of distinct pools of secretory granules.
This raises the interesting question of how the secretory gran-
ules can distinguish between Ca2+ entering the cell in response
to the two  different stimuli. Factors that may  be relevant in this
context include the nature of the electrical stimulus (sustained
depolarization vs.  brief action potentials) as well as biochemical
effects inﬂuencing the release probability of the secretory gran-
ules.
The existence of biochemically distinct population of secretory
granules is supported by the recent and elegant FRET-based studies
by Takahashi et al. [69]. These authors demonstrate that the SNARE
complexes in -cell exist in different states of ‘pre-assembly’. Gran-
ules with pre-assembled SNARE complexes (high-FRET) undergo
rapid exocytosis. Tentatively, this subset of granules corresponds to
those that undergo exocytosis in response to depolarization alone.
In addition, a time- and Ca2+-dependent assembly of SNARE com-
plexes was  observed that preceded slower exocytosis, that may
represent the mobilization of new granules for release. Finally,
they observed rapid assembly of SNARE complexes preceding ‘crash
fusion events’ (i.e. newcomer release) triggered by glucose.
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Fig. 4. Ca2+-channels and glucagon exocytosis evoked by hypoglycaemia alone and
in  the presence of adrenaline. (A) Action potential generated under hypoglycaemic
conditions leads to opening of non-L-type (presumably P/Q-type) Ca2+-channels
and  localized increases in [Ca2+]i that trigger exocytosis of the few glucagon-
containing secretory granules (SG) that happen to be situated close enough to these
Ca2+-channels. During the action potentials, L-type Ca2+-channels also open but exo-
cytosis of secretory granules is not triggered (spatial separation?). (B) In the presence
of adrenaline, cAMP increases and activates the cAMP-sensor Epac2. Under these
conditions, Ca2+-entry via L-type Ca2+-channels triggers Ca2+-induced Ca2+-release
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Ca2+]i rises throughout the -cell triggering exocytosis of all release-competent
ranules.
. Ca2+-dependent exocytosis in -cells: role of L- and
on-L-type Ca2+-channels
During -cell electrical activity both L- and non-L-type Ca2+-
hannels (N- or P/Q-type; see discussion above) open. In mouse
-cells, L-type Ca2+-channels mediate most of the Ca2+-entry
uring the action potentials but glucagon secretion evoked by
ow glucose alone is almost resistant to isradipine or nifedipine
29,70,71].  Conversely, blocking non-L-type Ca2+-channels, whilst
aving only a weak effect on [Ca2+]i, inhibits glucagon secretion as
trongly as elevation of glucose to >6 mM [71]. This suggests that -
ells remain capable of generating action potentials even when the
-type Ca2+-channel activity is completely suppressed. In this con-
ext it may  be pertinent that -cells in freshly isolated mouse islets
re equipped with voltage-gated Na+-channels and that the Na+-
urrent amplitude is 5–10-fold larger than all the Ca2+-currents
ogether. During these action potentials, non-L-type Ca2+-channels
ay  still open and trigger exocytosis of the glucagon vesicles. How-
ver, it remains obscure why Ca2+-entry via L-type Ca2+-channels
s such a poor initiator of glucagon secretion although L-type Ca2+-
hannels outnumber non-L-type Ca2+-channels by a factor of four.
erhaps the simplest explanation is that L- and non-L-type Ca2+-
hannels are spatially segregated so that their active zones do
ot overlap (Fig. 4A). Because non-L-type HVA Ca2+-channels only
pen during the peak of the action potential, a reduction of action
otential height can (as discussed above) be expected to have dra-
atic effects on glucagon secretion. This explains why tolbutamide
nhibits glucagon secretion from both mouse and human islets [32].
pplication of tolbutamide to -cells leads to strong membrane
epolarization and (via voltage-dependent inactivation of the Na+-
hannels) to a marked reduction of spike height [32,34]. Thus, even
t the peak of the action potential the non-L-type Ca2+-channels
o not activate sufﬁciently to trigger exocytosis (Fig. 2A). We  are
urrently investigating whether glucose exerts a tolbutamide-like
ffect on -cell electrical activity. If this turns out to be the case, it
ould explain how elevation of glucose inhibits glucagon secretionm 51 (2012) 300– 308 305
without a detectable decrease in [Ca2+]i in -cells in intact mouse
[72] and human islets (Fig. 2B). Indeed, the blocker of P/Q-type Ca2+-
channels has only a small effect on [Ca2+]i in spontaneously active
-cells in human islets exposed to 1 mM  glucose and yet strongly
inhibits glucagon secretion [34]. If elevation of glucose, via reduced
action potential amplitude, leads to a similar reduction of P/Q-type
Ca2+-channel activity, then this effect would be equally difﬁcult to
detect in [Ca2+]i measurements.
Collectively, these observations are suggestive of a dichotomy
between [Ca2+]i and glucagon secretion. It is tempting to specu-
late that Ca2+-entry via L-type Ca2+-channels at elevated glucose is
linked to cellular processes other than glucagon secretion. It was
recently reported that human -cells secrete acetylcholine and
it was  proposed that this, via activation of muscarinic receptors,
increases the responsiveness of neighbouring -cells to increases
in glucose [73]. However, if acetylcholine was secreted by the same
mechanism as glucagon, then its release (like glucagon) would be
suppressed when glucose is elevated (i.e. under conditions where
it was postulated to enhance insulin secretion). Thus, Ca2+ entry via
two  different Ca2+-channels may  allow two  exocytotic pathways to
operate in parallel within the -cell (Fig. 2D).
Whereas L-type Ca2+-channels play only a minor role in
glucagon secretion evoked by low glucose alone, the situa-
tion changes dramatically when glucagon secretion is stimulated
by adrenaline [74]. The stimulation of glucagon secretion by
adrenaline is an important component of the counter-regulatory
response of the -cell to hypoglycaemia, which becomes defec-
tive in diabetic patients [3].  It could be argued that understanding
the processes involved in counter-regulation in the healthy -
cell provides the knowledge base necessary to pharmacologically
restore it in the diabetic -cell. Intriguingly, the stimulation of
glucagon secretion by adrenaline is associated with a switch in the
Ca2+-channel dependence from non-L-type to L-type Ca2+-channels
[55,74]. Thus, glucagon secretion evoked by adrenaline is strongly
inhibited by isradipine or nifedipine.
The stimulatory effect of adrenaline on glucagon secretion is
mediated by cAMP by a PKA-independent mechanism that involves
the cAMP-sensing protein Epac2 [55,74].  We  previously proposed
that this recruits secretory granules to the L-type Ca2+-channels
[53]. However, more recent experiments (own unpublished) sug-
gest that Ca2+-entry via L-type Ca2+-channels when Epac2 is
activated (by high intracellular cAMP) promotes Ca2+-induced
Ca2+-release (CICR) from intracellular Ca2+ stores. We  speculate
that the resulting global elevation of [Ca2+]i within the -cell
triggers exocytosis of any release-competent secretory granules
regardless of their proximity to the Ca2+-channels (Fig. 4B) and this
accounts for the massive stimulation of glucagon secretion.
8. Ca2+-channels, [Ca2+]i and diabetes
As should be evident from the discourse above, Ca2+-channels
and [Ca2+]i are intimately linked to the both insulin and glucagon
secretion. Is this information relevant to the understanding of the
pathophysiology of type-2 diabetes?
Whereas acute exposure of pancreatic islets to free fatty acids
results in stimulation of insulin secretion [75], protracted expo-
sure (48 h or more) impairs glucose-induced insulin secretion [76].
The underlying mechanism has been difﬁcult to unravel and it has
been attributed to impaired metabolism, hyperactivation of KATP-
channels and even reduced -cell mass due to increased -cell
death [77,78].With the fairly detailed understanding of the stimulus-secretion
coupling of the pancreatic -cell we  thought it would be straight-
forward to pinpoint the changes produced by long-term exposure
to FFAs such as palmitate and oleate. Surprisingly, -cells exposed
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o FFAs for 72 h performed better than control cells not exposed to
FAs when key functional parameters like glucose metabolism (ATP
roduction), KATP-channel closure, glucose-induced elevation of
Ca2+]i, Ca2+-currents and exocytosis (measured in response to 500-
s depolarizations) were analyzed. Likewise, there were no signs of
ncreased -cell death or reduced insulin content/biosynthesis that
ould explain the reduction of glucose-induced insulin secretion
76].
We subsequently discovered that long-term exposure to FFAs
esults in a selective suppression of exocytosis elicited by brief
action potential-like) depolarizations. Thus, exocytosis in response
o 50-ms depolarizations was strongly reduced. By contrast, con-
istent with our earlier data [76], exocytosis evoked by longer
epolarizations (>300 ms)  was not affected. This selective sup-
ression of exocytosis evoked by short (action potential-like)
epolarizations correlated with dispersion of Ca2+-entry. Whereas
epolarization-induced Ca2+-entry is concentrated to discrete
reas in control cells (Fig. 3B), it becomes more diffuse in -cells
xposed to FFAs (Fig. 3C). Because of the loss of Ca2+-channel
ggregation, release-competent granules may  not be exposed to
xocytotic levels of [Ca2+]i during the brief action potentials of the
-cells (Fig. 3D–E). However, insulin secretion can be rescued by
rolonging the duration of the voltage-clamp depolarizations to
300 ms.  During such long depolarizations, there is enough time
or Ca2+ to diffuse within the cell to produce a global elevation of
Ca2+]i that eventually triggers exocytosis also of granules that are
ot situated in the immediate vicinity of the Ca2+-channels.
Long-term FFA exposure also interfered with glucose-
timulated insulin secretion from human islets. In both mouse
nd human islets [60], the suppression of glucose-induced insulin
ecretion resulting from chronic FFA exposure could be reversed
y addition of the broad-spectrum K+-channel blocker TEA. This
ompound blocks the K+-channels involved in action potential
epolarization and thereby extends the duration of the action
otentials. This allows the Ca2+-channels to stay open longer
mimicking the effects of long voltage-clamp depolarizations),
esulting in a more global elevation of [Ca2+]i than in response to
rief action potentials. Thus, Ca2+-channel dispersion may  underlie
he suppression of glucose-induced insulin secretion by long-term
FA exposure also in human islets.
The functional consequences of Ca2+-channel dissociation may
e particularly strong in the -cell because it operates with so few
a2+-channels. In cells with a higher Ca2+-channel density (like
hromafﬁn cells), dispersion of the Ca2+-channels and dissociation
f the granule/Ca2+-channel complexes can be expected to have
 much smaller effect because the secretory granules will almost
lways be situated in the close vicinity of one or several voltage-
ated Ca2+-channels.
What is the physiological signiﬁcance of Ca2+-channel disper-
ion in response to long-term FFA exposure? We  propose that
his provides the -cells with a means to suppress insulin secre-
ion during fasting/starvation. Under these conditions, plasma FFA
ncreases to >1 mM  whilst plasma glucose, by activation of gluco-
enic mechanisms, is maintained >3.5 mM [79]. Normally, the
ombination of this glucose concentration and FFAs would lead
o strong stimulation of insulin secretion. This is clearly inap-
ropriate during starvation when metabolism should be geared
owards mobilization of glucose rather than its disposal. It is possi-
le that this evolutionarily preserved mechanism, which originally
eveloped to suppress insulin secretion during food deprivation,
ecomes erroneously activated when plasma and/or intra-islet lev-
ls become elevated via excessive dietary intake of lipids [80]. It
s easy to see how this can lead to a vicious cycle of progressive
mpairment of insulin secretion and elevation of plasma FFA lev-
ls until overt type-2 diabetes presents in genetically predisposed
ndividuals [81].
[m 51 (2012) 300– 308
Because of limited availability of islets from donors with type-2
diabetes (T2D), the impact type-2 diabetes on -cell [Ca2+]i remains
unknown. However, work on -cells from GK rats, a model of non-
obese human T2D with elevated plasma FFA levels [82], found no
impairment in the capacity of glucose to elevate [Ca2+]i and only
subtle changes in exocytosis manifested as a ∼50% reduction of the
Ca2+-sensitivity of exocytosis [83]. The dispersion of Ca2+-channels
we observe following long-term FFA exposure can be expected to
result in an apparent reduction of the Ca2+-sensitivity of exocytosis
but whether this underlies the diminished insulin secretion in GK-
rats (and in islets from T2D donors) remains to be demonstrated
experimentally.
9. Coda
It is rewarding to compare Ca2+-signalling in pancreatic - and
-cells. Such studies may  reveal processes that are key to the recip-
rocal glucose-sensing in the two cell types. It is also important to
note that there are numerous and important differences between
human and rodent islet cells. This illustrates the potential pitfalls
of uncritically extrapolating observations made in rodent systems
to the situation in man. Finally, there appears to be some truth
to the adage that “you are what you eat”, at least when it comes
to Ca2+-signalling in the -cell. As we have discussed above, diets
that lead to protracted exposure of the -cells to FFAs may  exert
adverse effects on the -cell’s capacity to secrete insulin in response
to glucose.
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